No. 135 / 16 February 2021
To: BUCHAREST STOCK EXCHANGE
FINANCIAL SUPERVISORY AUTHORITY
drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations, as amended and completed
Report Date: 16 February 2021
Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")
Unique Registration Code at the National Office of Trade Registry: 8422035
Order number on the Trade Registry: J40/3709/1996
Subscribed and paid-in share capital: 33,217,623 RON
Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category
Significant events to report:
Audit report according to art. 923 paragraph (5) of Law no. 24/2017, as amended and completed by Law no. 158/2020
Med Life S.A. inform the shareholders and investors regarding the issuance of the Independent Limited Assurance Report on the information included in the current report prepared by Med Life S.A. in accordance with the provisions of Law no. 24/2017, as revised, and FSA Regulation no. 5/2018.
The report in attached to the present current report.
Chief Executive Officer